BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17487430)

  • 1. The action of GLP-1 and exendins upon glucose transport in normal human adipocytes, and on kinase activity as compared to morbidly obese patients.
    Sancho V; Nuche B; Arnés L; Cancelas J; González N; Díaz-Miguel M; Martín-Duce A; Valverde I; Villanueva-Peñacarrillo ML
    Int J Mol Med; 2007 Jun; 19(6):961-6. PubMed ID: 17487430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of glucagon-like peptide-1 and exendins on kinase activity, glucose transport and lipid metabolism in adipocytes from normal and type-2 diabetic rats.
    Sancho V; Trigo MV; González N; Valverde I; Malaisse WJ; Villanueva-Peñacarrillo ML
    J Mol Endocrinol; 2005 Aug; 35(1):27-38. PubMed ID: 16087719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of GLP-1 on glucose transport and its cell signalling in human myocytes.
    González N; Acitores A; Sancho V; Valverde I; Villanueva-Peñacarrillo ML
    Regul Pept; 2005 Mar; 126(3):203-11. PubMed ID: 15664668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of GLP-1 and exendins action upon glucose transport and metabolism in type 2 diabetic rat skeletal muscle.
    Arnés L; González N; Tornero-Esteban P; Sancho V; Acitores A; Valverde I; Delgado E; Villanueva-Peñacarrillo ML
    Int J Mol Med; 2008 Jul; 22(1):127-32. PubMed ID: 18575785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristic of GLP-1 effects on glucose metabolism in human skeletal muscle from obese patients.
    Villanueva-Peñacarrillo ML; Martín-Duce A; Ramos-Álvarez I; Gutiérrez-Rojas I; Moreno P; Nuche-Berenguer B; Acitores A; Sancho V; Valverde I; González N
    Regul Pept; 2011 Jun; 168(1-3):39-44. PubMed ID: 21419173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of GLP-1 on D-glucose transport, lipolysis and lipogenesis in adipocytes of obese subjects.
    Sancho V; Trigo MV; Martín-Duce A; Gonz Lez N; Acitores A; Arnés L; Valverde I; Malaisse WJ; Villanueva-Peñacarrillo ML
    Int J Mol Med; 2006 Jun; 17(6):1133-7. PubMed ID: 16685426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalizing action of exendin-4 and GLP-1 in the glucose metabolism of extrapancreatic tissues in insulin-resistant and type 2 diabetic states.
    Moreno P; Nuche-Berenguer B; Gutiérrez-Rojas I; Acitores A; Sancho V; Valverde I; González N; Villanueva-Peñacarrillo ML
    J Mol Endocrinol; 2012 Feb; 48(1):37-47. PubMed ID: 22065862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GLP-1 signalling and effects on glucose metabolism in myocytes from type 2 diabetic patients.
    González N; Sancho V; Martín-Duce A; Tornero-Esteban P; Valverde I; Malaisse WJ; Villanueva-Peñacarrillo ML
    Int J Mol Med; 2005 Oct; 16(4):747-52. PubMed ID: 16142415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes.
    Luque MA; González N; Márquez L; Acitores A; Redondo A; Morales M; Valverde I; Villanueva-Peñacarrillo ML
    J Endocrinol; 2002 Jun; 173(3):465-73. PubMed ID: 12065236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes.
    El Bekay R; Coín-Aragüez L; Fernández-García D; Oliva-Olivera W; Bernal-López R; Clemente-Postigo M; Delgado-Lista J; Diaz-Ruiz A; Guzman-Ruiz R; Vázquez-Martínez R; Lhamyani S; Roca-Rodríguez MM; Veledo SF; Vendrell J; Malagón MM; Tinahones FJ
    Br J Pharmacol; 2016 Jun; 173(11):1820-34. PubMed ID: 26993859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent effects of GLP-1 analogs exendin-4 and exendin-9 on the expression of myosin heavy chain isoforms in C2C12 myotubes.
    Wang L; Guo F; Wei S; Zhao R
    Peptides; 2011 Jun; 32(6):1313-9. PubMed ID: 21453734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation of protein kinases in the stimulant action of GLP-1 on 2-deoxy-D-glucose uptake by normal rat skeletal muscle.
    Acitores A; González N; Sancho V; Arnés L; Valverde I; Malaisse WJ; Villanueva-Peñacarrillo ML
    Horm Metab Res; 2005 May; 37(5):275-80. PubMed ID: 15971149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exendin-4 increases insulin sensitivity via a PI-3-kinase-dependent mechanism: contrasting effects of GLP-1.
    Idris I; Patiag D; Gray S; Donnelly R
    Biochem Pharmacol; 2002 Mar; 63(5):993-6. PubMed ID: 11911852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans.
    Vella A; Shah P; Reed AS; Adkins AS; Basu R; Rizza RA
    Diabetologia; 2002 Oct; 45(10):1410-5. PubMed ID: 12378382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide-1(7-36) amide (GLP-1) enhances insulin-stimulated glucose metabolism in 3T3-L1 adipocytes: one of several potential extrapancreatic sites of GLP-1 action.
    Egan JM; Montrose-Rafizadeh C; Wang Y; Bernier M; Roth J
    Endocrinology; 1994 Nov; 135(5):2070-5. PubMed ID: 7956929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-1(7-36)amide enhances insulin-stimulated glucose uptake and decreases intracellular cAMP content in isolated rat adipocytes.
    Miki H; Namba M; Nishimura T; Mineo I; Matsumura T; Miyagawa J; Nakajima H; Kuwajima M; Hanafusa T; Matsuzawa Y
    Biochim Biophys Acta; 1996 Jun; 1312(2):132-6. PubMed ID: 8672535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 in cultured preadipocyte-derived adipocytes and myotubes of obese subjects.
    Sajan MP; Standaert ML; Miura A; Bandyopadhyay G; Vollenweider P; Franklin DM; Lea-Currie R; Farese RV
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3994-8. PubMed ID: 15292339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in glucagon-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects.
    Valverde I; Puente J; Martín-Duce A; Molina L; Lozano O; Sancho V; Malaisse WJ; Villanueva-Peñacarrillo ML
    Obes Surg; 2005 Mar; 15(3):387-97. PubMed ID: 15826475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expression.
    Kim Chung le T; Hosaka T; Yoshida M; Harada N; Sakaue H; Sakai T; Nakaya Y
    Biochem Biophys Res Commun; 2009 Dec; 390(3):613-8. PubMed ID: 19850014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion.
    Lugari R; Dei Cas A; Ugolotti D; Barilli AL; Camellini C; Ganzerla GC; Luciani A; Salerni B; Mittenperger F; Nodari S; Gnudi A; Zandomeneghi R
    Horm Metab Res; 2004 Feb; 36(2):111-5. PubMed ID: 15002062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.